IL159807A0 - Solid composition containing bacillus-type non-pathogenic bacterial spores - Google Patents

Solid composition containing bacillus-type non-pathogenic bacterial spores

Info

Publication number
IL159807A0
IL159807A0 IL15980702A IL15980702A IL159807A0 IL 159807 A0 IL159807 A0 IL 159807A0 IL 15980702 A IL15980702 A IL 15980702A IL 15980702 A IL15980702 A IL 15980702A IL 159807 A0 IL159807 A0 IL 159807A0
Authority
IL
Israel
Prior art keywords
composition containing
solid composition
type non
bacterial spores
pathogenic bacterial
Prior art date
Application number
IL15980702A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo Otc Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Otc Spa filed Critical Sanofi Synthelabo Otc Spa
Publication of IL159807A0 publication Critical patent/IL159807A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
IL15980702A 2001-07-27 2002-07-26 Solid composition containing bacillus-type non-pathogenic bacterial spores IL159807A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001632A ITMI20011632A1 (it) 2001-07-27 2001-07-27 Composizione solida contenente spore di batteri non patogeni del genere bacillus
PCT/EP2002/008384 WO2003011341A1 (fr) 2001-07-27 2002-07-26 Composition solide contenant des spores de bacteries non pathogenes du genre bacillus

Publications (1)

Publication Number Publication Date
IL159807A0 true IL159807A0 (en) 2004-06-20

Family

ID=11448170

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15980702A IL159807A0 (en) 2001-07-27 2002-07-26 Solid composition containing bacillus-type non-pathogenic bacterial spores
IL159807A IL159807A (en) 2001-07-27 2004-01-11 Solid composition containing bacillus-type non-pathogenic bacterial spores

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159807A IL159807A (en) 2001-07-27 2004-01-11 Solid composition containing bacillus-type non-pathogenic bacterial spores

Country Status (32)

Country Link
US (2) US8039006B2 (no)
EP (1) EP1429808B1 (no)
JP (1) JP4913986B2 (no)
KR (2) KR20090099022A (no)
CN (1) CN1323720C (no)
AT (1) ATE462448T1 (no)
AU (1) AU2002333278B2 (no)
BR (1) BRPI0211453B1 (no)
CA (1) CA2454389C (no)
CO (1) CO5560587A2 (no)
CY (1) CY1112608T1 (no)
DE (1) DE60235819D1 (no)
DK (1) DK1429808T3 (no)
EA (1) EA006847B1 (no)
ES (1) ES2356325T3 (no)
GE (2) GEP20063721B (no)
HK (1) HK1061644A1 (no)
HR (1) HRP20040066B1 (no)
HU (1) HU229652B1 (no)
IL (2) IL159807A0 (no)
IT (1) ITMI20011632A1 (no)
MA (1) MA27051A1 (no)
MX (1) MXPA04000835A (no)
NO (1) NO332656B1 (no)
NZ (1) NZ530743A (no)
PL (1) PL209647B1 (no)
PT (1) PT1429808E (no)
SI (1) SI1429808T1 (no)
TN (1) TNSN04018A1 (no)
UA (1) UA81225C2 (no)
WO (1) WO2003011341A1 (no)
ZA (1) ZA200400440B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599631B2 (en) 2001-01-26 2003-07-29 Nanogram Corporation Polymer-inorganic particle composites
KR100931948B1 (ko) * 2007-06-26 2009-12-15 영남대학교 산학협력단 제올라이트를 이용한 바실러스 포자의 열 안정성 향상 방법
BE1018018A6 (nl) 2008-02-28 2010-04-06 Gielen Cornelis Oplossing voor het biologisch reinigen van tandenborstels en bijhorende inrichting.
BR122016030511B1 (pt) 2008-04-07 2017-07-04 Bayer Intellectual Property Gmbh Composition understanding biological control and fungicid agents, method for treating a plant, and spray formulation for treatment or application in sulco
KR20110007168A (ko) * 2008-04-07 2011-01-21 바이엘 크롭사이언스 엘피 안정한 포자-함유 수성 제제
IT1393931B1 (it) * 2009-02-25 2012-05-17 Neuroscienze Pharmaness S C A R L Composizione di spore di batteri non patogeni
WO2011120530A1 (en) * 2010-03-31 2011-10-06 Lifecycle Phama A/S Porous tablets as carriers for liquid formulations
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
SG10201704035TA (en) * 2012-11-23 2017-06-29 Seres Therapeutics Inc Synergistic bacterial compositions and methods of production and use thereof
KR102222273B1 (ko) 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
EP2951283A4 (en) 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
KR102379658B1 (ko) 2013-11-25 2022-03-28 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
FR3125945A1 (fr) * 2021-08-03 2023-02-10 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
GB8425487D0 (en) * 1984-10-09 1984-11-14 Agricultural Genetics Co Strain of bacillus thuringiensis
DE3707160A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag Bacillus polymyxa enthaltende mittel zur verabreichung an tiere
JPH0761255B2 (ja) 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
DE4404702A1 (de) * 1994-02-15 1995-08-31 Hoechst Schering Agrevo Gmbh Wasserdispergierbare Granulate auf der Basis lebender Organismen
JP4194114B2 (ja) * 1994-02-23 2008-12-10 ビーエム リサーチ エイ／エス 制御放出組成物
CA2192086C (en) * 1994-06-15 2000-01-25 Tomas Norling Pellets
DE4442255A1 (de) * 1994-11-28 1996-05-30 Bayer Ag Schädlingsbekämpfungsmittel
JP3180886B2 (ja) 1995-06-07 2001-06-25 旭化成株式会社 動物成長促進剤
EP1067945B1 (en) * 1998-04-01 2006-01-04 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US6924133B1 (en) * 1999-10-01 2005-08-02 Novozymes A/S Spray dried enzyme product
US6387874B1 (en) * 2001-06-27 2002-05-14 Spartan Chemical Company, Inc. Cleaning composition containing an organic acid and a spore forming microbial composition

Also Published As

Publication number Publication date
DE60235819D1 (de) 2010-05-12
PT1429808E (pt) 2010-06-23
WO2003011341A1 (fr) 2003-02-13
HK1061644A1 (en) 2004-09-30
EA006847B1 (ru) 2006-04-28
HUP0402024A2 (hu) 2005-01-28
HUP0402024A3 (en) 2005-06-28
EP1429808A1 (fr) 2004-06-23
DK1429808T3 (da) 2010-07-19
CA2454389C (fr) 2011-07-12
CN1323720C (zh) 2007-07-04
KR20040032868A (ko) 2004-04-17
CY1112608T1 (el) 2016-02-10
MA27051A1 (fr) 2004-12-20
US8039006B2 (en) 2011-10-18
HRP20040066A2 (en) 2004-06-30
AU2002333278B2 (en) 2007-05-31
NO332656B1 (no) 2012-11-26
US8551498B2 (en) 2013-10-08
ZA200400440B (en) 2005-03-30
KR100970787B1 (ko) 2010-07-16
BRPI0211453B1 (pt) 2018-04-03
BR0211453A (pt) 2004-08-17
ITMI20011632A1 (it) 2003-01-27
ATE462448T1 (de) 2010-04-15
GEP20053721B (en) 2006-01-10
PL209647B1 (pl) 2011-09-30
EP1429808B1 (fr) 2010-03-31
NO20040347L (no) 2004-03-26
MXPA04000835A (es) 2004-05-14
CN1558776A (zh) 2004-12-29
SI1429808T1 (sl) 2010-11-30
EA200400072A1 (ru) 2004-08-26
UA81225C2 (en) 2007-12-25
US20120009167A1 (en) 2012-01-12
NZ530743A (en) 2005-08-26
TNSN04018A1 (fr) 2006-06-01
ITMI20011632A0 (it) 2001-07-27
KR20090099022A (ko) 2009-09-18
CA2454389A1 (fr) 2003-02-13
HU229652B1 (en) 2014-03-28
US20040241772A1 (en) 2004-12-02
HRP20040066B1 (en) 2012-02-29
CO5560587A2 (es) 2005-09-30
IL159807A (en) 2010-05-31
GEP20063721B (en) 2006-01-10
JP2004538311A (ja) 2004-12-24
PL366984A1 (en) 2005-02-07
JP4913986B2 (ja) 2012-04-11
ES2356325T3 (es) 2011-04-07

Similar Documents

Publication Publication Date Title
HK1061644A1 (en) Solid composition containing bacillus-type non-pathogenic bacterial spores
MY125941A (en) New lactobacillus strains preventing diarrhoea caused by pathogenic bacteria
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
YU101503A (en) A novel engineered superantigen for human therapy
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
WO2005000878A3 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
IL156942A0 (en) Compounds, pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
AP1563A (en) Lactic acid bacteria for the treatment and /or prophylaxis of giardiasis.
AU2001256708A1 (en) Method of screening compound having antimicrobial activity on pathogenic microorganism infecting organism having acquired immune mechanism by using organism having natural immune mechanism alone, and method of evaluating the antimicrobial activity by using organism having natural
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
AU2003230228A1 (en) Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
PL1615656T3 (pl) Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje
WO2005034971A3 (en) Antiviral agent
WO2006066224A3 (en) Virulence targeted antibiotics
UA64347C2 (en) Strain of bacteria of lactobacillus acidophilus being used in the production of bacterial preparations for functional diary products
WO2003053959A8 (de) Heterocyclylaminocarbo nyluracile
AR045293A1 (es) Un promotor de crecimiento a base de la bacteria "bacillus megatherium" para aplicar en agricultura y el metodo para su desarrollo